Quick Order Cart

Cat. No. ARG27704

KPNA1 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The KPNA1 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the human near-haploid HAP1 cell line, enabling functional studies of the KPNA1 gene. KPNA1 encodes importin alpha-1, an adaptor that binds classical nuclear localization signals (cNLS) on cargo proteins and, together with importin beta-1 (KPNB1), mediates nuclear import through the nuclear pore complex. This polyclonal knockout model is useful for examining nucleocytoplasmic transport, viral host factor requirements (e.g., influenza, HIV), and importin-specific cargoes such as STAT1 and p53. Applications include fluorescent import assays, co-immunoprecipitation, and genetic screens. These cells provide a robust platform for dissecting importin-dependent signaling and drug targeting.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    KPNA1

    Gene Identifier

    NCBI Gene ID 3836

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KPNA1 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from human HAP1 cells, featuring disruption of the KPNA1 gene. This loss-of-function model comprises a heterogeneous pool of edited cells, enabling study of importin alpha-1-dependent nuclear import without clonal selection. KPNA1 encodes an adaptor that recognizes classical nuclear localization signals (cNLS) on cargo proteins and, together with importin beta-1 (KPNB1), facilitates transport through the nuclear pore complex.

HAP1 is a near-haploid chronic myeloid leukemia cell line with adherent fibroblast-like morphology, derived from KBM-7. Its haploid genome allows unambiguous loss-of-function phenotypes upon single-allele gene disruption, making it a powerful platform for genetic screens and functional genomics. HAP1 cells retain key signaling pathways relevant to cancer and cellular transport, and their use in KPNA1 knockout studies eliminates the potential for diploid compensation.

KPNA1 is a core component of the classical nuclear import pathway. It binds cNLS motifs on transcription factors such as STAT1, NF-??B, and p53, forming a complex with KPNB1 that interacts with nucleoporins NUP50 and NUP153 to traverse the nuclear pore. The Ran GTPase cycle provides directionality: RanGTP dissociates the complex in the nucleus. KPNA1 expression is regulated by E2F transcription factors, and casein kinase 2 (CK2) phosphorylates KPNA1 to modulate cargo binding. In viral infections, KPNA1 mediates nuclear import of the influenza virus nucleoprotein and HIV Rev protein, underscoring its broad host-factor role.

In the HAP1 context, KPNA1 disruption abrogates importin alpha-1-specific transport, permitting the dissection of cargo specificity and functional redundancy among importin alpha isoforms. Given the hematopoietic origin of HAP1, this model is suited for studying nuclear import-dependent signaling in leukemia, including potential defects in p53 or STAT1 nuclear accumulation. Additionally, the polyclonal knockout population enables investigation of viral host-factor requirements, where loss of KPNA1 may impair replication of influenza virus or HIV.

Applications include fluorescent NLS reporter assays to measure import kinetics, viral infection assays, co-immunoprecipitation of importin complexes, and subcellular fractionation with western blotting. The polyclonal format facilitates functional genomics screens and transcriptomic analyses (RNA-seq) to discover KPNA1-dependent pathways. These cells are also valuable for testing small-molecule inhibitors of nuclear transport. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)